









市场行情
/
股票
/
nasdaq-idxx
/

IDEXX实验室

IDXX

700.550USD

-3.650-0.52%

收盘 12/15, 16:00（美东）报价延迟15分钟

56.04B总市值

55.13市盈率 TTM



IDEXX实验室

700.550

-3.650-0.52%

概览公司财务分析

概览

公司

财务

分析

关于 IDEXX实验室公司

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX实验室简介



公司代码IDXX

公司名称IDEXX Laboratories Inc

上市日期Jun 21, 1991

CEOEmerson (Andrew)

员工数量11000

证券类型Ordinary Share

年结日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编04092-2041

电话12075560300

网址https://www.idexx.com/

公司代码IDXX

上市日期Jun 21, 1991

CEOEmerson (Andrew)

IDEXX实验室公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

名称

名称/职务

职务

持股

持股变动

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

地区USD

名称

营收

占比

United States

717.87M

64.70%

Europe & Middle East & Africa (EMEA) (Region)

233.27M

21.03%

Asia Pacific

89.30M

8.05%

Canada

46.69M

4.21%

Latin America

22.33M

2.01%

业务

地区

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

12.43%

BlackRock Institutional Trust Company, N.A.

6.56%

State Street Investment Management (US)

4.41%

Fundsmith LLP

3.27%

Geode Capital Management, L.L.C.

3.13%

其他

70.21%

持股股东

占比

The Vanguard Group, Inc.

12.43%

BlackRock Institutional Trust Company, N.A.

6.56%

State Street Investment Management (US)

4.41%

Fundsmith LLP

3.27%

Geode Capital Management, L.L.C.

3.13%

其他

70.21%

股东类型

持股股东

占比

Investment Advisor

53.77%

Investment Advisor/Hedge Fund

30.95%

Research Firm

3.98%

Pension Fund

2.91%

Bank and Trust

1.86%

Individual Investor

0.69%

Sovereign Wealth Fund

0.59%

Hedge Fund

0.54%

Family Office

0.50%

其他

4.22%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

2319

77.76M

97.19%

-4.03M

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

9.84M

12.3%

+19.20K

+0.20%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.30M

6.63%

-132.86K

-2.44%

Jun 30, 2025

State Street Investment Management (US)

3.55M

4.44%

-95.45K

-2.62%

Jun 30, 2025

Fundsmith LLP

2.64M

3.3%

-9.04K

-0.34%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.46M

3.08%

+54.40K

+2.26%

Jun 30, 2025

Baron Capital Management, Inc.

2.03M

2.54%

-27.16K

-1.32%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

1.65M

2.06%

-5.80K

-0.35%

Aug 31, 2025

Principal Global Investors (Equity)

1.13M

1.41%

+1.75K

+0.16%

Jun 30, 2025

Polen Capital Management, LLC

1.20M

1.49%

+1.12M

+1519.07%

Jun 30, 2025

Walter Scott & Partners Ltd.

756.69K

0.95%

+597.11K

+374.18%

Jun 30, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

ProShares Pet Care ETF

9.4%

iShares U.S. Medical Devices ETF

4.42%

First Trust Water ETF

3.98%

SMI 3Fourteen Full-Cycle Trend ETF

3.9%

Nuveen ESG Mid-Cap Growth ETF

3.47%

Adaptive Core ETF

2.61%

First Trust S&P 500 Economic Moat Index ETF

2.25%

Acruence Active Hedge US Equity ETF

2.18%

Tema Durable Quality ETF

2.1%

Putnam Sustainable Future ETF

2.03%

ProShares Pet Care ETF

占比9.4%

iShares U.S. Medical Devices ETF

占比4.42%

First Trust Water ETF

占比3.98%

SMI 3Fourteen Full-Cycle Trend ETF

占比3.9%

Nuveen ESG Mid-Cap Growth ETF

占比3.47%

Adaptive Core ETF

占比2.61%

First Trust S&P 500 Economic Moat Index ETF

占比2.25%

Acruence Active Hedge US Equity ETF

占比2.18%

Tema Durable Quality ETF

占比2.1%

Putnam Sustainable Future ETF

占比2.03%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

IDEXX实验室的前五大股东是谁？



IDEXX实验室的前五大股东如下：
The Vanguard Group, Inc.持有股份：9.84M，占总股份比例：12.30%。
BlackRock Institutional Trust Company, N.A.持有股份：5.30M，占总股份比例：6.63%。
State Street Investment Management (US)持有股份：3.55M，占总股份比例：4.44%。
Fundsmith LLP持有股份：2.64M，占总股份比例：3.30%。
Geode Capital Management, L.L.C.持有股份：2.46M，占总股份比例：3.08%。